Ardego Therapeutics, Inc. — Form D

Ardego Therapeutics, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2026-06-03. The offering totals $3.0M, of which $50K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-06-03
• Form: D
• Accession: 0002138133-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $3.0M
• Amount sold: $50K
• Remaining: $3.0M
• Investors: 1
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-585947

Issuer

• Name: Ardego Therapeutics, Inc.
• CIK: 0002138133
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 207A PERRY PARKWAY, SUITE 6, GAITHERSBURG, MD, 20877
• Phone: 402-980-9184

Officers, directors & promoters (2)

More

• CIK 2138133 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search